Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.
暂无分享,去创建一个
Y. Pommier | L. Rubinstein | L. Jia | J. Doroshow | A. Chen | R. Parchment | G. Melillo | W. Bonner | S. Kummar | M. Hollingshead | A. Murgo | J. Reid | M. Ames | Yiping Zhang | J. Ji | R. Kinders | J. Tomaszewski | G. Speranza | H. Stotler | John Carter | Lihua H. Wang | M. Weil